Tolebrutinib shows disability-progression delay in non-relapsing secondary progressive MS
A major step forward in the treatment of Multiple sclerosis (MS) has been reported with the Phase 3…
tolebrutinib
Tolebrutinib – Nuovo farmaco per la sclerosi multipla: efficacia, meccanismo d’azione e prospettive
Tolebrutinib: il nuovo BTK‑inibitore per la sclerosi multipla progressiva Cos’è la sclerosi multipla (SM) La sclerosi multipla (SM)…